Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Atkins

Showing results (1-10 of 493) with videos related to

Pageof 50
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Cytokine-based therapy and biochemotherapy for advanced melanomaMichael B Atkins
Medical Oncology (Northwood, London, England)|January 24, 2009
Treatment selection for patients with metastatic renal cell carcinoma: identification of features favoring upfront IL-2-based immunotherapyMichael B Atkins
Hematology/Oncology Clinics of North America|October 6, 1998
Immunotherapy and experimental approaches for metastatic melanomaM B Atkins
Seminars in Oncology|June 18, 2002
Interleukin-2: clinical applicationsMichael B Atkins
Current Opinion in Oncology|March 1, 1997
The treatment of metastatic melanoma with chemotherapy and biologicsM B Atkins
International Journal of Antimicrobial Agents|October 21, 1999
Fusidic acid in bone and joint infectionsB Atkins, T Gottlieb
Sports Medicine (Auckland, N.Z.)|March 30, 2000
Infectious diseases in rugby players: incidence, treatment and preventionA Stacey, B Atkins
The Lancet. Oncology|February 2, 2013
Which drug, and when, for patients with BRAF-mutant melanoma?Sekwon Jang, Michael B Atkins
British Medical Journal|November 23, 1974
Communications between general practitioners and consultantsA Long, J B Atkins
Clinical Pharmacology and Therapeutics|October 2, 2013
Treatment of BRAF-mutant melanoma: the role of vemurafenib and other therapiesS Jang, M B Atkins
Pageof 50

Showing results (1-10 of 493) with videos related to

Sort By:
Pageof 50
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Cytokine-based therapy and biochemotherapy for advanced melanomaMichael B Atkins
Medical Oncology (Northwood, London, England)|January 24, 2009
Treatment selection for patients with metastatic renal cell carcinoma: identification of features favoring upfront IL-2-based immunotherapyMichael B Atkins
Hematology/Oncology Clinics of North America|October 6, 1998
Immunotherapy and experimental approaches for metastatic melanomaM B Atkins
Seminars in Oncology|June 18, 2002
Interleukin-2: clinical applicationsMichael B Atkins
Current Opinion in Oncology|March 1, 1997
The treatment of metastatic melanoma with chemotherapy and biologicsM B Atkins
International Journal of Antimicrobial Agents|October 21, 1999
Fusidic acid in bone and joint infectionsB Atkins, T Gottlieb
Sports Medicine (Auckland, N.Z.)|March 30, 2000
Infectious diseases in rugby players: incidence, treatment and preventionA Stacey, B Atkins
The Lancet. Oncology|February 2, 2013
Which drug, and when, for patients with BRAF-mutant melanoma?Sekwon Jang, Michael B Atkins
British Medical Journal|November 23, 1974
Communications between general practitioners and consultantsA Long, J B Atkins
Clinical Pharmacology and Therapeutics|October 2, 2013
Treatment of BRAF-mutant melanoma: the role of vemurafenib and other therapiesS Jang, M B Atkins
Pageof 50